APA (7th ed.) Citation

Wagner, H., Angiolillo, D. J., ten Berg, J. M., Bergmeijer, T. O., Jakubowski, J. A., Small, D. S., . . . Erlinge, D. (2014). Higher body weight patients on clopidogrel maintenance therapy have lower active metabolite concentrations, lower levels of platelet inhibition, and higher rates of poor responders than low body weight patients. Journal of thrombosis and thrombolysis, 38(2), 127-136. https://doi.org/10.1007/s11239-013-0987-8

Chicago Style (17th ed.) Citation

Wagner, Henrik, et al. "Higher Body Weight Patients on Clopidogrel Maintenance Therapy Have Lower Active Metabolite Concentrations, Lower Levels of Platelet Inhibition, and Higher Rates of Poor Responders than Low Body Weight Patients." Journal of Thrombosis and Thrombolysis 38, no. 2 (2014): 127-136. https://doi.org/10.1007/s11239-013-0987-8.

MLA (9th ed.) Citation

Wagner, Henrik, et al. "Higher Body Weight Patients on Clopidogrel Maintenance Therapy Have Lower Active Metabolite Concentrations, Lower Levels of Platelet Inhibition, and Higher Rates of Poor Responders than Low Body Weight Patients." Journal of Thrombosis and Thrombolysis, vol. 38, no. 2, 2014, pp. 127-136, https://doi.org/10.1007/s11239-013-0987-8.